Recent Updates
Recently added Catalysts
OBIO Positive Sentiment Score: 70/100

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Friday, February 13, 2026 1 min read
Key Takeaway: Orchestra BioMed Holdings, Inc. has granted stock options to nine newly hired employees as part of its 2025 New Hire Inducement Plan. Specifically, the Compensation Committee of the Board of Directors awarded options to purchase a total of 120,000 shares of common stock. The vesting period for these options is set at four years, reflecting the company's commitment to attract and retain talent while adhering to Nasdaq Listing Rule 5635(c)(4). This initiative underlines Orchestra BioMed's focus on growth through strategic partnerships in the biomedical sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • Orchestra BioMed is expanding its team by hiring new employees.
  • The stock options granted will motivate new hires and enhance retention.
  • This move supports the company's strategic growth and compliance with Nasdaq rules.

Full Press Release Details

NEW HOPE, Pa., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, reported today that, on February 12, 2026, the Compensation Committee of the Orchestra BioMed Board of Directors granted stock options to purchase an aggregate of 120,000 shares of the Company’s common stock to nine newly hired employees. The awards were granted pursuant to the Orchestra Biomed Holdings, Inc. 2025 New Hire Inducement Plan as an inducement material to each new employee entering employment with Orchestra Biomed, in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options granted to each new employee will vest over a four-year period.
Orchestra Biomed is providing this information in accordance with Nasdaq Listing Rule 5635(c)(4).
About Orchestra BioMed
Snewcomb@orchestrabiomed.com
kkirkellis@orchestrabiomed.com

Frequently Asked Questions

What recent action did Orchestra BioMed take regarding stock options?

Orchestra BioMed granted stock options for 120,000 shares to nine new employees.

Under which plan were the stock options granted?

The options were granted under the 2025 New Hire Inducement Plan.

How will the stock options vest for new employees?

The stock options will vest over a period of four years.

What rule does this action comply with?

This action is in accordance with Nasdaq Listing Rule 5635(c)(4).

Who can be contacted for more information about Orchestra BioMed?

Inquiries can be directed to Snewcomb or Kkirkellis at Orchestra BioMed.

Tags: OBIO Viatris Investor Conferences Healthcare Orchestra BioMed stock options Nasdaq new hires biomedical
Last updated: Feb 13, 2026